PAEA is playing an active role in developing collaborative relationships with organizations that are leaders in behavioral health and substance use disorder treatment. The PAEA Opioid Response Network Clinical Sites Initiative is forging a path to increase and enhance the PA workforce pipeline for behavioral health practices treating patients with opioid use disorder (OUD). This initiative is made possible by a sub-award from the American Academy of Addiction Psychiatry’s (AAAP’s) State Opioid Response Technical Assistance (SOR-TA) grant through the Substance Abuse and Mental Health Services Administration (SAMHSA).
How does clinical experience prepare PA students for practice?
Members of collaborating organizations contribute to the training of PA students by:
Providing students with the opportunity to advocate for those impacted by the social determinants of mental health that influence the risk for OUD
Providing PA students with the opportunity to acquire skills needed to identify patients at risk for OUD and to care for patients with OUD
Providing students with the opportunity to recognize patients with dual diagnoses and to provide treatment for OUD
Providing students with the opportunity to observe and manage patients undergoing multi-disciplinary treatment utilizing Medication-Assisted Treatment (MAT)
Download our Power Point on Enhancing the Behavioral Health Workforce Through PA Training and Recruitment.
Download this fact sheet explaining the Opioid Response Network-2/SORTA Program: Clinical Sites Initiative.
In the NewsMore ▶︎
- American Society of Addiction Medicine (ASAM)
- Association for Addiction Professionals (NAADAC)
- American Psychiatric Association (APA)
- American Osteopathic Academy of Addiction Medicine (AOAAM)
- National Association of Addiction Treatment Providers (NAATP)
Funding for this initiative was made possible by grant no. 1H79 TI083343-01 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.